Drug Could Hamper Bone Growth
Study Findings:
- A common class of drugs prescribed to children with depression, selective serotonin-reuptake inhibitors, may have an adverse effect on bone growth.
These findings indicate a potential negative impact of SSRIs on the skeleton and point to a need for further research into the prescribing of these drugs to children and adolescents, said lead author Stuart J. Warden, assistant professor in the I.U. Department of Physical Therapy.
The study investigated the effects of fluoxetine, commonly known as Prozac, on bone growth in young mice. Warden and his colleagues selected fluoxetine because it is the only prescription antidepressant currently approved by the FDA for children and adolescents.
Related Articles:
- Original Research: Inhibition of the serotonin transporter (5-HTT) reduces bone accrual during growth
- Drug Could Hamper Bone Growth
Recent Entries
- Laughing is good for the heart
- Absence of critical protein linked to infertility
- Head and neck cancer research
- Vertebroplasty and fractures
- Smoking while pregnant causes finger, toe deformities
- Dogs can smell early-stage cancer!
- Understanding fatigue in chronic liver disease
- Immune substances may help antibody-based drugs fight cancer
- Asthma txt alerts!
- New depression research